189333-46-8 Usage
General Description
9-benzyl-2,4-dioxo-3,9-diazaspiro[5.5]undecane-1,5-dicarbonitrile is a specialized organic chemical compound that belongs to the class of spirans, more specifically, the spirodihydrofurans. Spirans, including this specific compound, are part of a larger class of organic compounds which also exhibit bicyclic structural properties, meaning they consist of two connected ring structures. While there isn't a lot of specific information available about this chemical, general properties like melting point, boiling point, and solubility could be expected as per its structural configuration. Given its complex structure, this compound is likely used in advanced scientific research and could have potential applications in drug synthesis or material science.
Check Digit Verification of cas no
The CAS Registry Mumber 189333-46-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,3,3 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 189333-46:
(8*1)+(7*8)+(6*9)+(5*3)+(4*3)+(3*3)+(2*4)+(1*6)=168
168 % 10 = 8
So 189333-46-8 is a valid CAS Registry Number.
189333-46-8Relevant articles and documents
3,9- DIAZASPIRO[5,5] UNDECANE COMPOUND AS FLT3 AND AXL INHIBITORS
-
Paragraph 0019; 0225, (2021/08/05)
Disclosed in the present invention is a novel compound as FLT3 and AXL inhibitors. Sepcifically, disclosed are a compound represented by fomula (I) and a pharmacologically acceptable salt thereof.
Polymorphism of novel spiroarylphosphine oxide
-
Paragraph 0125-0128, (2019/11/20)
The invention relates to a polymorphic substance of a compound (2-((5-chloro-2-((2-methoxyl-4-(9-methyl-3,9-diaza-sprio[5.5]hendecane-3-yl)phenyl)amino)pyrimidine-4-yl)amino)phenyl)dimethyl phosphineoxide (compound I). The invention further relates to a m
Spiro aryl phosphorus oxide or sulfide
-
Paragraph 0324; 0325; 0326; 0327, (2016/10/08)
The invention discloses a spiro aryl phosphorus oxide or sulfide as ALK inhibitor, and in particular discloses a compound shown in a formula (I) as an ALK inhibitor or a pharmaceutically acceptable salt thereof.